MaxCyte, Inc. (MXCT) Financials
MXCT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 266.7 million | 33.4 million |
2023-06-30 | 271.2 million | 30.2 million |
2023-03-31 | 281.5 million | 33.7 million |
2022-12-31 | 286.7 million | 32.7 million |
MXCT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -9.0 million | 3.6 million |
2023-06-30 | -10.6 million | 3.5 million |
2023-03-31 | -5.9 million | 3.3 million |
2022-12-31 | -8.3 million | 3.1 million |
MXCT Net Income
No data available :(
MXCT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 190.2 million | - | 16.1 million |
2023-06-30 | 216.1 million | - | 16.2 million |
2023-03-31 | 224.7 million | - | 16.3 million |
2022-12-31 | 227.3 million | - | 16.1 million |
MXCT Shares Outstanding
MXCT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 720200 | 6.3 million | 6.8 million | 7.0 million |
2023-06-30 | 507000 | 5.7 million | 7.7 million | 6.4 million |
2023-03-31 | 1.6 million | 6.0 million | 7.5 million | 6.3 million |
2022-12-31 | 2.2 million | 5.7 million | 5.6 million | 5.4 million |
MXCT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 8.0 million | 793400 |
2023-06-30 | 9.0 million | 1.4 million |
2023-03-31 | 8.6 million | 999800 |
2022-12-31 | 12.4 million | 1.5 million |
MXCT
Price: $3.83
52 week price:
Earnings Per Share: -0.37 USD
P/E Ratio: -13.22
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 508900
Market Capitalization: 429.8 million